CYYNF
Price
$0.14
Change
-$0.05 (-26.32%)
Updated
Jan 6 closing price
Capitalization
29.37M
INKT
Price
$0.88
Change
+$0.05 (+6.02%)
Updated
Jan 17 closing price
Capitalization
34.87M
60 days until earnings call
Ad is loading...

CYYNF vs INKT

Header iconCYYNF vs INKT Comparison
Open Charts CYYNF vs INKTBanner chart's image
Cynata Therapeutics
Price$0.14
Change-$0.05 (-26.32%)
Volume$3.3K
Capitalization29.37M
MiNK Therapeutics
Price$0.88
Change+$0.05 (+6.02%)
Volume$95K
Capitalization34.87M
CYYNF vs INKT Comparison Chart
Loading...
CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYYNF vs. INKT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYYNF is a Hold and INKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CYYNF: $0.14 vs. INKT: $0.88)
Brand notoriety: CYYNF and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYYNF: 396% vs. INKT: 77%
Market capitalization -- CYYNF: $29.37M vs. INKT: $34.87M
CYYNF [@Biotechnology] is valued at $29.37M. INKT’s [@Biotechnology] market capitalization is $34.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYYNF’s FA Score shows that 0 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • CYYNF’s FA Score: 0 green, 5 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, INKT is a better buy in the long-term than CYYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYYNF’s TA Score shows that 0 TA indicator(s) are bullish while INKT’s TA Score has 5 bullish TA indicator(s).

  • CYYNF’s TA Score: 0 bullish, 3 bearish.
  • INKT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INKT is a better buy in the short-term than CYYNF.

Price Growth

CYYNF (@Biotechnology) experienced а 0.00% price change this week, while INKT (@Biotechnology) price change was +20.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

INKT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($34.9M) has a higher market cap than CYYNF($29.4M). INKT YTD gains are higher at: 26.273 vs. CYYNF (-27.368).
CYYNFINKTCYYNF / INKT
Capitalization29.4M34.9M84%
EBITDAN/A-14.07M-
Gain YTD-27.36826.273-104%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A6.33M-
Total DebtN/A4.61M-
FUNDAMENTALS RATINGS
CYYNF: Fundamental Ratings
CYYNF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYYNFINKT
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bearish Trend 11 days ago
46%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
43%
Bullish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
41%
Bullish Trend 11 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
URA28.030.67
+2.45%
Global X Uranium ETF
YYY11.830.04
+0.34%
Amplify High Income ETF
PBDC35.030.03
+0.09%
Putnam BDC Income ETF
RITA19.34N/A
+0.02%
ETFB Green SRI REITs ETF
SURE119.66N/A
N/A
AdvisorShares Insider Advantage ETF

CYYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with CADL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYYNF
1D Price
Change %
CYYNF100%
N/A
CADL - CYYNF
46%
Loosely correlated
-13.33%
URGN - CYYNF
38%
Loosely correlated
-2.38%
MLLCF - CYYNF
31%
Poorly correlated
N/A
INKT - CYYNF
27%
Poorly correlated
+5.77%
BRTX - CYYNF
26%
Poorly correlated
-2.72%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
+5.77%
RAIN - INKT
43%
Loosely correlated
+7.73%
CRIS - INKT
40%
Loosely correlated
+3.46%
CADL - INKT
35%
Loosely correlated
-13.33%
ABCZF - INKT
33%
Loosely correlated
N/A
TERN - INKT
30%
Poorly correlated
-1.56%
More